Jane Street’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Sell
109,700
-353,900
-76% -$54.4M ﹤0.01% 1877
2025
Q4
$80.7M Sell
463,600
-318,800
-41% -$58.2M 0.01% 685
2025
Q3
$113M Buy
782,400
+44,600
+6% +$5.46M 0.02% 533
2025
Q2
$74.3M Sell
737,800
-4,200
-0.6% -$321K 0.01% 577
2025
Q1
$56.6M Buy
742,000
+7,500
+1% +$574K 0.01% 607
2024
Q4
$50.7M Sell
734,500
-308,300
-30% -$22.2M 0.01% 695
2024
Q3
$76.1M Sell
1,042,800
-45,600
-4% -$3.37M 0.02% 497
2024
Q2
$72.9M Buy
1,088,400
+884,400
+434% +$34.3M 0.02% 522
2024
Q1
$5.53M Buy
204,000
+190,600
+1,422% +$5.33M ﹤0.01% 2479
2023
Q4
$415K Sell
13,400
-32,400
-71% -$840K ﹤0.01% 7086
2023
Q3
$1.16M Buy
45,800
+9,300
+25% +$213K ﹤0.01% 4961
2023
Q2
$770K Buy
+36,500
New +$693K ﹤0.01% 5649
2022
Q4
Sell
-54,200
Closed -$1.17M 9591
2022
Q3
$1.17M Buy
54,200
+21,600
+66% +$518K ﹤0.01% 5140
2022
Q2
$643K Buy
+32,600
New +$683K ﹤0.01% 6284
2022
Q1
Sell
-32,500
Closed -$885K 10652
2021
Q4
$885K Buy
32,500
+22,200
+216% +$635K ﹤0.01% 6148
2021
Q3
$284K Buy
10,300
+100
+1% +$2.62K ﹤0.01% 8302
2021
Q2
$290K Sell
10,200
-14,600
-59% -$433K ﹤0.01% 8201
2021
Q1
$845K Sell
24,800
-8,800
-26% -$336K ﹤0.01% 5777
2020
Q4
$1.12M Buy
33,600
+2,400
+8% +$87.7K ﹤0.01% 4462
2020
Q3
$1M Sell
31,200
-30,400
-49% -$874K ﹤0.01% 4095
2020
Q2
$1.7M Buy
61,600
+39,600
+180% +$939K ﹤0.01% 3288
2020
Q1
$353K Buy
+22,000
New +$521K ﹤0.01% 4029
2017
Q4
Sell
-23,000
Closed -$718K 4862
2017
Q3
$718K Buy
+23,000
New +$438K ﹤0.01% 2667

Other funds holding INSM

Jane Street's INSM Position: Q1 2026 in Review

Jane Street reduced its Insmed (INSM) stake by 16% in Q1 2026, selling an estimated $323K and leaving 11,401 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #5232.

Jane Street first reported a position in INSM in Q2 2013 and has held it in 35 quarters since. The position peaked at $136M in Q2 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Jane Street held 11,401 shares of Insmed worth $1.86M as of Q1 2026.
  • Jane Street sold 2,104 Insmed shares in Q1 2026, an estimated $323K.
  • Insmed made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5232 holding.
  • Jane Street first reported a position in Insmed in Q2 2013 and has held it in 35 quarters since.
  • Jane Street's Insmed position peaked at $136M in Q2 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.